106 related articles for article (PubMed ID: 1491763)
1. [Long-term local tolerability to intranasally administered salmon calcitonin in post-menopausal osteoporosis].
Gariboldi LM; Bolla I; Baroni MC; Delsignore R; Passeri M; Barberis F
Minerva Med; 1992 Dec; 83(12):827-31. PubMed ID: 1491763
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of calcitonin tolerance after intramuscular or intranasal administration in treatment for postmenopausal osteoporosis].
Horst-Sikorska W; Ruszkowska J; Kosowicz J
Przegl Lek; 1996; 53(1):9-11. PubMed ID: 8711177
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin.
Silverman SL
Am J Med Sci; 1997 Jan; 313(1):13-6. PubMed ID: 9001161
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin intranasal--unigene: Salcatonin intranasal--unigene.
Drugs R D; 2004; 5(2):90-3. PubMed ID: 15293868
[TBL] [Abstract][Full Text] [Related]
6. [Multicenter comparative study of synthetic salmon calcitonin administered nasally in the treatment of established postmenopausal osteoporosis].
Abellán Pérez M; Bayina García FJ; Calabozo M; Carpintero Benítez P; Figueroa Pedrosa M; Fernández Crisóstomo C; García López A; García Pérez S; Mesa Ramos M; Paulino Tevar J
An Med Interna; 1995 Jan; 12(1):12-6. PubMed ID: 7718710
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin and the treatment of osteoporosis.
Schneyer CR
Md Med J; 1991 Jun; 40(6):469-73. PubMed ID: 1861574
[TBL] [Abstract][Full Text] [Related]
8. Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
Gennari C; Agnusdei D; Camporeale A
Osteoporos Int; 1993; 3 Suppl 1():208-10. PubMed ID: 8461563
[No Abstract] [Full Text] [Related]
9. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
Downs RW; Bell NH; Ettinger MP; Walsh BW; Favus MJ; Mako B; Wang L; Smith ME; Gormley GJ; Melton ME
J Clin Endocrinol Metab; 2000 May; 85(5):1783-8. PubMed ID: 10843152
[TBL] [Abstract][Full Text] [Related]
10. Oral salmon calcitonin--pharmacology in osteoporosis.
Henriksen K; Bay-Jensen AC; Christiansen C; Karsdal MA
Expert Opin Biol Ther; 2010 Nov; 10(11):1617-29. PubMed ID: 20932224
[TBL] [Abstract][Full Text] [Related]
11. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study.
Pontiroli AE; Pajetta E; Scaglia L; Rubinacci A; Resmini G; Arrigoni M; Pozza G
Aging (Milano); 1994 Dec; 6(6):459-63. PubMed ID: 7748920
[TBL] [Abstract][Full Text] [Related]
12. Intranasal salmon calcitonin. A review of its pharmacological properties and potential utility in metabolic bone disorders associated with aging.
Clissold SP; Fitton A; Chrisp P
Drugs Aging; 1991; 1(5):405-23. PubMed ID: 1794028
[TBL] [Abstract][Full Text] [Related]
13. [Intra-nasal calcitonin for the prevention of postmenopausal osteoporosis].
Meunier PJ
Rev Med Univ Navarra; 1992; 37(4):200-4. PubMed ID: 1298037
[No Abstract] [Full Text] [Related]
14. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
[TBL] [Abstract][Full Text] [Related]
15. Intranasal complications in women with osteoporosis under treatment with nasal calcitonin spray: case reports and review of the literature.
Chatziavramidis A; Mantsopoulos K; Gennadiou D; Sidiras T
Auris Nasus Larynx; 2008 Sep; 35(3):417-22. PubMed ID: 18053666
[TBL] [Abstract][Full Text] [Related]
16. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
[TBL] [Abstract][Full Text] [Related]
17. Calcitonins: newer routes of delivery.
Reginster JY
Osteoporos Int; 1993; 3 Suppl 2():S3-6; discussion S6-7. PubMed ID: 8481597
[TBL] [Abstract][Full Text] [Related]
18. Use of calcitonin in 20 patients suffering from postmenopausal osteoporosis. A proposal for a therapeutical scheme.
Lanciani P; Porzio V; Cattani D
Panminerva Med; 1991; 33(2):119-20. PubMed ID: 1923555
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Paget's disease of bone with salmon calcitonin nasal spray.
Gagel RF; Logan C; Mallette LE
J Am Geriatr Soc; 1988 Nov; 36(11):1010-4. PubMed ID: 3171038
[TBL] [Abstract][Full Text] [Related]
20. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.
Pun KK; Chan LW
Clin Ther; 1989; 11(2):205-9. PubMed ID: 2660996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
